Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cutaneous T-Cell Lymphoma PDX Drug Screening Platform Identifies Cooperation between Inhibitions of PI3Kα/δ and HDAC
Chi-Heng Wu, Chen‐Yen Yang, Linlin Wang, et al.
Journal of Investigative Dermatology (2020) Vol. 141, Iss. 2, pp. 364-373
Open Access | Times Cited: 18

Showing 18 citing articles:

Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures
Alberto Herrera, Anthony Cheng, Eleni P. Mimitou, et al.
Blood (2021) Vol. 138, Iss. 16, pp. 1456-1464
Open Access | Times Cited: 60
The functional and clinical roles of liquid biopsy in patient-derived models
Ziqing Zhu, Erya Hu, Hong Shen, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 27
Aggressive NK Cell Leukemia: Current State of the Art
Siba El Hussein, L. Jeffrey Medeiros, Joseph D. Khoury
Cancers (2020) Vol. 12, Iss. 10, pp. 2900-2900
Open Access | Times Cited: 39
Targeting CD70 in cutaneous T-cell lymphoma using an antibody-drug conjugate in patient-derived xenograft models
Chi-Heng Wu, Linlin Wang, Chen‐Yen Yang, et al.
Blood Advances (2021) Vol. 6, Iss. 7, pp. 2290-2302
Open Access | Times Cited: 18
Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma
Raman Preet Kaur Gill, Jennifer Gantchev, Amelia Martínez Villarreal, et al.
Cells (2022) Vol. 11, Iss. 4, pp. 593-593
Open Access | Times Cited: 11
Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives (Review)
Jessica Cao, Wing Hei Chan, Moses Chow
International Journal of Oncology (2022) Vol. 60, Iss. 5
Open Access | Times Cited: 11
A comparative study of tumour-on-chip models with patient-derived xenografts for predicting chemotherapy efficacy in colorectal cancer patients
Louis Jun Ye Ong, Shumei Chia, Stephen Qi Rong Wong, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 11
Validation of AAC-11-Derived Peptide Anti-Tumor Activity in a Single Graft Sézary Patient-Derived Xenograft Mouse Model
Justine Habault, Nicolas Thonnart, C. Ram‐Wolff, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 2933-2933
Open Access | Times Cited: 8
How can we establish animal models of HIV‐associated lymphoma?
Qing Xiao, Liuyue Zhai, Xiaomei Zhang, et al.
Animal Models and Experimental Medicine (2024) Vol. 7, Iss. 4, pp. 484-496
Open Access | Times Cited: 1
Epigenetics in the Pathogenesis and Treatment of Cutaneous T-Cell Lymphoma
Ping Zhang, Mingzhi Zhang
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 7
Challenging Cutaneous T-Cell Lymphoma: What Animal Models Tell us So Far
Antonella Bresin, Elisabetta Caprini, Giandomenico Russo, et al.
Journal of Investigative Dermatology (2022) Vol. 142, Iss. 6, pp. 1533-1540
Open Access | Times Cited: 4
Serum cell‐free DNA as a new biomarker in cutaneous T‐cell lymphoma
Yuka Mizuno, S. Shibata, Tomomitsu Miyagaki, et al.
The Journal of Dermatology (2022) Vol. 49, Iss. 11, pp. 1124-1130
Closed Access | Times Cited: 4
BKM120 inhibits malignant rhabdoid tumor of the kidney through induction of apoptosis and G0/G1 phase arrest
Jiayan Liu, Tao Mi, Zhaoxia Zhang, et al.
European Journal of Pharmacology (2023) Vol. 951, pp. 175747-175747
Closed Access | Times Cited: 2
Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice
Jie Gao, Shumei Ren, Gabrielle Choonoo, et al.
Disease Models & Mechanisms (2023) Vol. 16, Iss. 10
Open Access | Times Cited: 2
ND-16: A Novel Compound for Inhibiting the Growth of Cutaneous T Cell Lymphoma by Targeting JAK2
Man Zhu, Yanhong Liu, Panpan Lei, et al.
Current Cancer Drug Targets (2022) Vol. 22, Iss. 4, pp. 328-339
Closed Access | Times Cited: 3
“Next top” mouse models advancing CTCL research
Yixin Luo, Frank R. de Gruijl, Maarten H. Vermeer, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
Sézary syndrome patient–derived models allow drug selection for personalized therapy
Fernando Gallardo, Evelyn Andrades, Arnau Iglesias, et al.
Blood Advances (2022) Vol. 6, Iss. 11, pp. 3410-3421
Open Access
Uncovering the Potential of Phosphatidylinositol 3-Kinase Inhibitors in Cutaneous T-Cell Lymphoma: Insights from High-Throughput In Vitro Screenings
Amber Loren Ong King, Fatima N. Mirza, Julia M. Lewis, et al.
Journal of Investigative Dermatology (2021) Vol. 142, Iss. 1, pp. 254-257
Closed Access
Page 1

Scroll to top